跳至主要内容
临床试验/NL-OMON47323
NL-OMON47323已完成不适用

To study the effect of LDL-cholesterol and LDL-cholesterol lowering on hematopoietic stem cells and circulating immune cells in familial hypercholesterolemia patients. - PRIME

Academisch Medisch Centrum0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 64(—)

入选标准

  • - Age > 18 years old
  • - Familial hypercholesterolemia (according to Dutch Lipid network criteria)
  • - No previous cardiovascular events
  • - No current lipid lowering treatment
  • - LDL-cholesterol > 4.9 mmol/L;Healthy controls:
  • - Age >= 18 years old
  • - No (previous) clinically significant health problems
  • - No current medication use

排除标准

  • 1. Malignant diseases or any clinically significant medical condition that could interfere with the conduct of the study in the opinion of the investigator.
  • 2. Chronic or recent (<1 month) infections and/or clinical signs of acute infection and/or CRP>10
  • 3. Auto-immune diseases
  • 4. Recent or chronic immunosuppressant or antibiotic usage
  • 5. Type I or II diabetes mellitus
  • 6. Inability or unwillingness to comply with the protocol requirements, or deemed by investigator to be unfit for the study.

研究者

相似试验